Medetomidine is replacing xylazine in Philly street fentanyl − creating new hurdles for health care providers and drug users
An emergency physician and nurse scientist explain what medetomidine is and how to respond if someone is overdosing on it.
FDA approves cabozantinib for adults and pediatric patients with pNET and epNET
The Food and Drug Administration approved cabozantinib, or Cabometyx, marketed by Exelixis (EXEL), for adult and pediatric patients 12 years of ...
Cancer Therapy Advisor22h
Gozellix Approved for Use in Patients With Prostate Cancer
The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.
Endocrinology Advisor10h
Baqsimi Approved for Severe Hypoglycemia Treatment in Younger Patients
The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.
The American Journal of Managed Care10h
FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors
With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in ...